Kazia Therapeutics Limited American Depositary Shares KZIA

$13.58 -19.64% at last close

Analyst Consensus

Consensus Rating
Buy (6 Buy · 0 Hold · 0 Sell)
Average Price Target
$26.33
Implied Upside
+93.9%
Price Target Range
$18.00 – $34.00
Analysts (12 mo)
6

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-08-13
Canaccord GenuityJohn Newman
 Initiates coverage on Buy $29
2026-07-15
BTIGKambiz Yazdi
 Reiterates Buy $34
2026-07-01
BTIGKambiz Yazdi
 Initiates coverage on Buy $34
2026-06-11
Lake Street
 Initiates coverage on Buy $32
2026-04-15
Laidlaw & Co.Yale Jen
 Initiates coverage on Buy $25
2026-01-28
HC Wainwright & Co.Sean Lee
 Reiterates Buy $18
2025-12-12
HC Wainwright & Co.Sean Lee
 Maintains Buy $13 → $18
2025-10-02
Maxim GroupNaz Rahman
 Maintains Buy $15 → $20
2025-07-10
HC Wainwright & Co.Sean Lee
 Maintains Buy $2 → $13
2025-06-11
Maxim GroupJason McCarthy
 Maintains Buy $15
2025-02-06
Maxim GroupJason McCarthy
 Initiates coverage on Buy $15
2024-07-12
HC Wainwright & Co.Sean Lee
 Reiterates Buy $100
2023-04-11
HC Wainwright & Co.Sean Lee
 Upgrades Neutral → Buy $100
2022-08-02
Maxim GroupJason McCarthy
 Downgrades Buy → Hold —
2022-08-02
HC Wainwright & Co.Sean Lee
 Downgrades Buy → Neutral —
2021-10-14
Maxim GroupNaureen Quibria
 Initiates coverage on Buy $900
2021-01-05
HC Wainwright & Co.Sean Lee
 Initiates coverage on Buy $850

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$13.58
Market Cap
$155.18 million
52-Week Range
$4.86 – $17.40
Average Volume
247K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.